Garcia E, Buzoianu-Anguiano V, Silva-Garcia R, Esparza-Salazar F, Arriero-Cabanero A, Escandon A
Int J Mol Sci. 2023; 24(18).
PMID: 37762251
PMC: 10531377.
DOI: 10.3390/ijms241813946.
Wei X, Ma W, Gu H, Liu D, Luo W, Cao S
Cell Prolif. 2022; 56(2):e13354.
PMID: 36266504
PMC: 9890536.
DOI: 10.1111/cpr.13354.
Asadniaye Fardjahromi M, Razmjou A, Vesey G, Ejeian F, Banerjee B, Mukhopadhyay S
RSC Adv. 2022; 10(34):20118-20128.
PMID: 35520442
PMC: 9054200.
DOI: 10.1039/d0ra04090h.
Xu X, Liang Z, Lin Y, Rao J, Lin F, Yang Z
Front Cell Neurosci. 2022; 16:860131.
PMID: 35444516
PMC: 9013778.
DOI: 10.3389/fncel.2022.860131.
Aboutaleb Kadkhodaeian H, Salati A, Ansari M, Nooshabadi V
Basic Clin Neurosci. 2022; 12(4):523-532.
PMID: 35154592
PMC: 8817176.
DOI: 10.32598/bcn.2021.12.4.2230.1.
Extracellular Vesicles Derived From Canine Mesenchymal Stromal Cells in Serum Free Culture Medium Have Anti-inflammatory Effect on Microglial Cells.
Kuwahara Y, Yoshizaki K, Nishida H, Kamishina H, Maeda S, Takano K
Front Vet Sci. 2021; 8:633426.
PMID: 33996963
PMC: 8113404.
DOI: 10.3389/fvets.2021.633426.
Effects of combination treatment with transcranial magnetic stimulation and bone marrow mesenchymal stem cell transplantation or Raf inhibition on spinal cord injury in rats.
Feng S, Wang S, Sun S, Su H, Zhang L
Mol Med Rep. 2021; 23(4).
PMID: 33649786
PMC: 7930933.
DOI: 10.3892/mmr.2021.11934.
Efficacy of autologous bone marrow mononuclear cell transplantation in dogs with chronic spinal cord injury.
Tamura K, Maeta N
Open Vet J. 2020; 10(2):206-215.
PMID: 32821665
PMC: 7419067.
DOI: 10.4314/ovj.v10i2.10.
The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury.
Ahuja C, Mothe A, Khazaei M, Badhiwala J, Gilbert E, van der Kooy D
Stem Cells Transl Med. 2020; 9(12):1509-1530.
PMID: 32691994
PMC: 7695641.
DOI: 10.1002/sctm.19-0135.
Clinical Trials of Stem Cell Treatment for Spinal Cord Injury.
Yamazaki K, Kawabori M, Seki T, Houkin K
Int J Mol Sci. 2020; 21(11).
PMID: 32498423
PMC: 7313002.
DOI: 10.3390/ijms21113994.
Canine mesenchymal stromal cell-conditioned medium promotes survival and neurite outgrowth of neural stem cells.
Nakamura M, Nishida H, Yoshizaki K, Akiyoshi H, Hatoya S, Sugiura K
J Vet Med Sci. 2020; 82(5):668-672.
PMID: 32249241
PMC: 7273601.
DOI: 10.1292/jvms.19-0141.
Early Intravenous Infusion of Mesenchymal Stromal Cells Exerts a Tissue Source Age-Dependent Beneficial Effect on Neurovascular Integrity and Neurobehavioral Recovery After Traumatic Cervical Spinal Cord Injury.
Vawda R, Badner A, Hong J, Mikhail M, Lakhani A, Dragas R
Stem Cells Transl Med. 2019; 8(7):639-649.
PMID: 30912623
PMC: 6591557.
DOI: 10.1002/sctm.18-0192.
Motor Recovery after Transplantation of Bone Marrow Mesenchymal Stem Cells in Rat Models of Spinal Cord Injury.
Muniswami D, Kanthakumar P, Kanakasabapathy I, Tharion G
Ann Neurosci. 2019; 25(3):126-140.
PMID: 30814821
PMC: 6388433.
DOI: 10.1159/000487069.
Cerebrospinal fluid-stem cell interactions may pave the path for cell-based therapy in neurological diseases.
Ren C, Yin P, Ren N, Wang Z, Wang J, Zhang C
Stem Cell Res Ther. 2018; 9(1):66.
PMID: 29523182
PMC: 5845187.
DOI: 10.1186/s13287-018-0807-3.
Magnetic resonance imaging tracking and assessing repair function of the bone marrow mesenchymal stem cells transplantation in a rat model of spinal cord injury.
Zhang H, Wang L, Wen S, Xiang Q, Xiang X, Xu C
Oncotarget. 2017; 8(35):58985-58999.
PMID: 28938612
PMC: 5601708.
DOI: 10.18632/oncotarget.19775.
Bone Marrow Mesenchymal Stem-Cell Transplantation Promotes Functional Improvement Associated with CNTF-STAT3 Activation after Hemi-Sectioned Spinal Cord Injury in Tree Shrews.
Xiong L, Liu F, Lu B, Zhao W, Dong X, Liu J
Front Cell Neurosci. 2017; 11:172.
PMID: 28701922
PMC: 5487382.
DOI: 10.3389/fncel.2017.00172.
Functional self-assembling peptide nanofiber hydrogel for peripheral nerve regeneration.
Wu X, He L, Li W, Li H, Wong W, Ramakrishna S
Regen Biomater. 2017; 4(1):21-30.
PMID: 28149526
PMC: 5274702.
DOI: 10.1093/rb/rbw034.
Macrophage polarization: a key event in the secondary phase of acute spinal cord injury.
Kong X, Gao J
J Cell Mol Med. 2016; 21(5):941-954.
PMID: 27957787
PMC: 5387136.
DOI: 10.1111/jcmm.13034.
The use of autologous neurogenically-induced bone marrow-derived mesenchymal stem cells for the treatment of paraplegic dogs without nociception due to spinal trauma.
Besalti O, Aktas Z, Can P, Akpinar E, Elcin A, Elcin Y
J Vet Med Sci. 2016; 78(9):1465-1473.
PMID: 27301583
PMC: 5059374.
DOI: 10.1292/jvms.15-0571.
Transplantation of choroid plexus epithelial cells into contusion-injured spinal cord of rats.
Kanekiyo K, Nakano N, Noda T, Yamada Y, Suzuki Y, Ohta M
Restor Neurol Neurosci. 2016; 34(3):347-66.
PMID: 26923614
PMC: 4927912.
DOI: 10.3233/RNN-150546.